The results of the largest and most comprehensive look at the impact of the Illinois Medical Cannabis Patient Experience Study – a statewide program that has examined patients since 2012 – shows the positive impact of medical cannabis among patients and the health care industry.
Conducted by Aclara Research, the study examined 300 of the 18,000 Illinois residents registered in the study.
The study found that 86 percent of survey respondents are managing leading symptoms of chronic pain. While chronic pain is not one of the 41 qualifying conditions in Illinois, cannabis shows strong potential in treating autoimmune diseases in which chronic inflammation plays a central role.
Key findings from the study include:
- Key gender gaps within the health care system as well as medical cannabis use:
- Across Illinois patients, women are up to 50 percent more likely to suffer with leading symptoms of chronic pain including trouble sleeping, back and joint pain, body ache and anxiety.
- Eighty six percent of patients reported suffering with symptoms of chronic pain.
- While not a qualifying condition for program participation in Illinois, patients are treating the leading symptoms of chronic pain which impacts more than 130 million Americans.